Applied Pharmaceutical Chemistry 2026

Pfizer, Cambridge, MA

Thursday, April 2, 2026

Stay tuned for the 2026 APC program!

We are putting together an excited lineup of speakers and topics, which will be announced soon.

Confirmed speakers for APC 2026

	Plenary Lecture: Greg Verdine, PhD Co-Founder, President, and CEO at LifeMine Therapeutics Title TBA

	Rebecca Swett, PhD Director of Computational Chemistry Innovation @ X-Chem Title TBA		Taylor Quinn, PhD Associate Principal Scientist @ AstraZeneca Title TBA

	Ludivine Moine, MSc Senior Scientist II @ Blueprint Medicines Design and Synthesis of BLU-654, a Potent and Selective Mutant KIT V654A Inhibitor for the Treatment of imatinib-resistant GIST

Join our LinkedIn Group

Sessions

Session I: TBA

Session II: TBA

Session III: TBA

Registration

Click here to register for the APC 2025 conference.

APC 2025 will take place April 10, 2025 at:

AstraZeneca, Waltham, MA

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3